2.5(top 7%)
Impact Factor
2.8(top 7%)
extended IF
54(top 7%)
H-Index
1.3K
authors
2K
papers
24.2K
citations
3.8K
citing journals
20.2K
citing authors

Most Cited Articles of Expert Review of Cardiovascular Therapy

TitleYearCitations
Neutrophil to lymphocyte ratio and cardiovascular diseases: a review2013372
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity2008340
Smoking and stroke: the more you smoke the more you stroke2010215
Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update2016172
Understanding the pathogenesis of abdominal aortic aneurysms2015171
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications2008171
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics2010139
Biomaterial applications in cardiovascular tissue repair and regeneration2012122
The failing Fontan: etiology, diagnosis and management2011122
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease2006121
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability2007118
Reactive oxygen species in vascular biology: role in arterial hypertension2003117
Ezetimibe: cholesterol lowering and beyond2008107
Systematic review of reversible cerebral vasoconstriction syndrome2010102
Shear stress and plaque development201099
Obesity and metabolic syndrome as related to cardiovascular disease201296
HDL dysfunction in diabetes: causes and possible treatments201292
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study)201191
Symptomatic and asymptomatic carotid artery plaque201189
Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease200885
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms201081
Prevention of venous thromboembolism in obesity201080
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?200679
Epidemiology of heart failure in sub-Saharan Africa200976
Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia200376